Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500095523Phase 4Not yet recruiting
Phase 4, randomised trial in sleep disorder comparing Esketamine intraoperative infusion with Normal saline intraoperative infusion (placebo) (2 arms). Primary endpoint: Incidence of postoperative sleep disorders on postoperative day 1 and day 3. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500095523.